Diskussion zur BICO Group Aktie WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: Hedgehog3

Den Bericht gönne ich mir natürlich nicht, aber schön, dass Cellink als  Keyplayer mit benannt wird: 3D Bioprinting Market to Grow by USD 1.24 Billion During 2020-2024 | Rising Cost Efficiency and Enhanced Productivity to Boost Growth https://www.businesswire.com/news/home/20201209005687/en/3D-Bioprinting-Market-to-Grow-by-USD-1.24-Billion-During-2020-2024-Rising-Cost-Efficiency-and-Enhanced-Productivity-to-Boost-Growth-Technavio Major Three 3D Bioprinting Market Participants: u.a. Cellink

CELLINK and Atelerix team up to enable the shipping at room temperature of fragile 3D bioprinted constructs by the world’s bioprinting community https://www.cellink.com/investors/press-release/?r=3268D5DA7CB0526C

Bezieht sich auf die Pressemitteilung vom 09.11. bzgl des TRIANKLE-Projekts: FC Barcelona unterstützt Forschungen zum 3D-Druck von Gewebe und Implantaten zur Knöchelregeneration https://www.3d-grenzenlos.de/magazin/forschung/fc-barcelona-3d-bioprinting-regeneration-von-knoechelgelenken-27638363/

Und noch mal aus Sicht vom Aktionär: https://www.deraktionaer.de/artikel/pharma-biotech/aktionaer-tipp-cellink-namhafte-verstaerkung-mitbegruender-von-moderna-kommt-20221428.html Seit einigen Monaten führt DER AKTIONÄR die Aktie von Cellink auf der Empfehlungsliste (zuvor im Aktienreport vorgestellt). Das schwedische Unternehmen agiert in einem extrem spannenden Zukunftsmarkt: dem Bioprinting. Ab dem kommenden Jahr erhält Cellink nun prominente Unterstützung im wissenschaftlichen Beirat. ...

👀

CELLINK begrüßt den neuen wissenschaftlichen Berater Professor Robert Langer vom MIT und Mitbegründer von Moderna https://www.cellink.com/investors/press-release/?r=E57D5DE66C35E7AA

Nein, aber habe es mal eingestellt wg Abstimmung über eine weitere KE.

Nimmst daran Teil?

The shareholders of CELLINK AB ...are hereby invited to the extraordinary general meeting on Thursday, 17th of December 2020.

https://www.cellink.com/investors/press-release/?r=5CBEECAAD05EF8D0 Notice of extraordinary general meeting of CELLINK AB u.a. Proposal to authorise the board of directors to resolve on new share issues (Item 7) The board of directors proposes that the extraordinary general meeting resolves to authorise the board of directors, for the period until the end of the next annual general meeting, at one or several occasions and with or without deviation from the shareholders’ preferential rights, to resolve on a new issue of shares of series B. The authorisation may be utilised for new issues of shares of series B, which may be made with provisions regarding contribution in cash, in kind or through set-off corresponding to a dilution of not more than 10 per cent of the registered chare capital in the company at the time of the issue resolution. In addition, in connection with acquisition of businesses, companies or rights, the board shall be able to resolve on issues in kind or through set-off corresponding to a further maximum 10 per cent of the registered share capital in the company at the time of the issue resolution. Thus, the total authorisation, corresponding to a maximum of 20 per cent, requires that at least 10 per cent be used for issues in kind or through set-off made in connection with the acquisition of businesses, companies or rights. The subscription price shall be determined on market terms and conditions. ...

👍

Danke

How 3D bioprinting could help usher in era of personalised medicine https://www.siliconrepublic.com/machines/3d-bioprinting-cellink-erik-gatenholm-personalised-medicine

3 lessons for every newbie founder competing with industry veterans https://thenextweb.com/growth-quarters/2020/11/10/3-lessons-i-learned-founding-a-startup-in-a-veteran-dominated-industry/ ... While outsiders may see CELLINK as an overnight success story with our recent $1 billion valuation and exponential growth, from an insider’s perspective  the notion of an overnight success is far from reality. ...

Cellink wird ja grundsätzlich noch seine Zeit brauchen.

Hilft der Aktie anscheinend auch nicht wirklich weiter. Alles geht hoch nur Cellink bleibt konstant :)